Xairos UK Ltd. as Prime Contractor, is leading a consortium with ViaSat and Heriot-Watt University to advance the development of satellite-based Quantum Time Transfer (QTT), a two-way time transfer ...

Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services in China, today announced that it has entered into a ...

The Global Revenue Cycle Management (RCM) Market is projected to grow from USD 449.83 billion in 2024 to USD 28560 billion by ...

Boost recruiter productivity and placement speed with the Ceipal–Ember integration, which embeds advanced Healthcare Staffing ...

FastGPT is more than just a no-code/low-code platform—it's a comprehensive AI solution designed to address the diverse needs of various industries and internal enterprise roles, with functions ...

As a leading tech company providing digital space integrated solutions, Realsee has built the world's largest 3D spatial database by replicating physical spaces, covering over 50 million spaces and ...

"Aaron brings an exceptional blend of technical expertise and customer-focused leadership," said Brook J. Lenfest, President & CEO of NetCarrier. "His ability to translate innovation into real-wold ...

Fintech Day & Awards will take place on November 10, 2025, at Convene Brookfield Place in New York City, and will bring together top executives, investors, and innovators from leading fintech ...

The new construction projects follow Ezee Fiber's successful Washington launch of service in Kent on October 22, 2025, and are part of the company's $400 million-plus commitment to expanding its ...

Southwest IDEAS 2025 Investor Conference (Dallas): Management will present on November 20, 2025 at 1:20 p.m. CT. Ligand management is scheduled to host one-on-one meetings with investors and attendees ...

Appointment strengthens the firm's growing managed services leadership team and expands delivery excellence for state and local government clients ...

Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced ...